Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | FPR2 | P25090 | 15/20 | 0.37 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8947434 | 0.95 | CNR2 (0.36) | GABRA1GABRB2FPR2HTR2CCNR2 | |
| SCHEMBL8947437 | 0.94 | GABRA1 (0.36) | GABRA1GABRB2FPR2CNR2 | |
| SCHEMBL8947445 | 0.93 | GABRA1 (0.36) | GABRA1GABRB2FPR2CNR2 | |
| SCHEMBL8947449 | 0.93 | GABRA1 (0.36) | GABRA1GABRB2FPR2CNR2 | |
| SCHEMBL8947442 | 0.93 | GABRA1 (0.36) | GABRA1GABRB2FPR2CNR2 | |
| SCHEMBL8947455 | 0.93 | GABRA1 (0.36) | GABRA1GABRB2FPR2CNR2 | |
| SCHEMBL8947422 | 0.93 | FPR2 (0.36) | GABRA1GABRB2FPR2HTR2CHTR2B | |
| SCHEMBL8945934 | 0.92 | GABRA1 (0.38) | GABRA1GABRB2FPR2HTR2CHTR2B | |
| SCHEMBL13579239 | 0.91 | GABRA1 (0.40) | GABRA1GABRB2FPR2HTR2CHTR2B | |
| SCHEMBL13579455 | 0.90 | GABRA1 (0.39) | GABRA1GABRB2FPR2HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187494-B2 | Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |